1118
M. Fitz et al. / Tetrahedron: Asymmetry 19 (2008) 1114–1119
CH2CH + COCH2CH2CH3), 2.13 (2H, t, J = 7.46 Hz,
COCH2CH2CH3), 2.55 (1H, m, CH3CH2CH), 3.35 (1H,
m, CH2NH), 3.51 (1H, m, CH2NH), 4.16 (2H, q, J =
7.20 Hz, OCH2CH3), 5.89 (1H, s, NH). 1H NMR
(400 MHz, CDCl3) d (ppm) for (R)-9: 0.94 (3H, t,
J = 7.46 Hz, CH3CH2CH), 1.26 (3H, t, J = 7.10 Hz,
OCH2CH3), 1.43 (9H, s, (CH3)3O), 1.53–1.69 (2H, m,
CH3CH2CH), 2.52 (1H, m, CH3CH2CH), 3.23–3.35 (2H,
m, CH2NH), 4.17 (2H, q, J = 7.13 Hz, OCH2CH3), 4.85
(1H, br s, NH).
tography [acetone/hexane (1:19)]. 1H NMR (400 MHz,
CDCl3) d (ppm) for (R)-10: 0.96 (6H, d, J = 6.88 Hz,
(CH3)2CH), 1.44 (9H, s, (CH3)3CO), 1.96 (1H, m,
(CH3)2CH), 2.43 (1H, m, (CH3)2CHCH), 3.24 (1H, m,
CH2NH), 3.41 (1H, m, CH2NH), 3.70 (3H, s, OCH3),
4.81 (1H, br s, NH).
Acknowledgements
The authors acknowledge the receipt of OTKA Grants K
71938 and T 049407.
The other half of the residue was dissolved in EtOAc
(30 mL) and extracted with 4% aqueous HCl (20 mL).
The aqueous phase was basified with aqueous KOH (8%)
and the free amino ester (R)-3 was extracted with EtOAc
(3 ꢃ 30 mL). The organic phase was dried over Na2SO4
and evaporated. This residue was used without further
purification to synthesise butyramide (R)-7, the antipode
of (S)-3 obtained from enzymatic resolution. The butyryla-
tion was carried out in pyridine (8 mL) with butanoic anhy-
dride (1.80 mL, 11.2 mmol; 2 equiv). The reaction mixture
was stirred overnight at room temperature. The next day,
20 mL of toluene was added to accelerate the evaporation.
References
1. Fulo¨p, F. Chem. Rev. 2001, 101, 2181–2204, and references
¨
cited therein.
2. Enantioselective Synthesis of b-Amino Acids; Juaristi, E.,
Soloshonok, V. A., Eds.; Wiley-VHC: New York, 2005.
3. Gademann, K.; Hintermann, T.; Schreiber, J. V. Curr. Med.
Chem. 1999, 6, 905–925.
4. Ojima, I.; Lin, S.; Wang, T. Curr. Med. Chem. 1999, 6, 927–
954.
5. Scarborough, R. M. Curr. Med. Chem. 1999, 6, 971–981.
6. Steer, D. L.; Lew, R. A.; Perlmutter, P.; Smith, A. I.; Aguilar,
M.-I. Curr. Med. Chem. 2002, 9, 811–822, and references
cited therein.
7. Denis, J.-N.; Greene, A. E. J. Am. Chem. Soc. 1988, 110,
5917–5919.
Purification by column chromatography [acetone/hexane
25
(2:8)] gave (R)-7 {260 mg (1.21 mmol, 89%); ½aꢁD ¼ ꢂ24:0
(c 1.0, MeOH); ee = 88%; ee did not decrease during the
reaction} as a colourless oil. The comparison of the specific
rotations of (R)-7 and (S)-7 confirmed the calculations
involving the use of an internal standard, which gave ee
1
(S)-7 = 95%. The H NMR (400 MHz, CDCl3) d (ppm)
8. Gellman, S. H. Acc. Chem. Res. 1998, 31, 173–180.
data for (R)-7 were similar to those for (S)-7.
´
9. Fulo¨p, F.; Martinek, T. A.; Toth, G. K. Chem. Soc. Rev.
¨
2006, 35, 323–334.
10. Martinek, T. A.; Fulo¨p, F. Eur. J. Biochem. 2003, 270, 3657–
¨
4.6. Preparative-scale resolution of methyl 3-amino-2-iso-
propylpropanoate, ( )-6
3666.
11. Liu, M.; Sibi, M. P. Tetrahedron 2002, 58, 7991–8035, and
references cited therein.
12. Della Rossa, C.; Gil, S.; Rodrıguez, P.; Parra, M. Synthesis
2006, 3092–3098.
13. Swiderska, M.; Stewart, J. D. Org. Lett. 2006, 8, 6131–
Racemic 6 (0.60 g, 4.8 mmol) was dissolved in tert-amyl
alcohol (80 mL). CAL-A preparation (4.80 g) and ethyl
butanoate (0.36 mL, 2.7 mmol) were added and the reac-
tion mixture was shaken at 4 °C. The reaction was stopped
after 26 days, at 40% conversion (ee (R)-6 = 52%, ee (S)-
8 = 78%), by filtering off the enzyme. After evaporation,
the residue was dissolved in 4% aqueous HCl and extracted
´
6133.
´
14. Moumne, R.; Denise, B.; Guitot, K.; Rudler, H.; Lavielle, S.;
Karoyan, P. Eur. J. Org. Chem. 2007, 1912–1920.
´
´
15. Dıaz-Sanchez, B. R.; Iglesias-Arteaga, M. A.; Melgar-Fern-
´
andez, R.; Juaristi, E. J. Org. Chem. 2007, 72, 4822–4825.
with EtOAc to obtain butyramide (S)-8 {390 mg
25
16. Chi, Y.; English, E. P.; Pomerantz, W. C.; Horne, W. S.;
Joyce, L. A.; Alexander, L. R.; Fleming, W. S.; Hopkins, E.
A.; Gellman, S. H. J. Am. Chem. Soc. 2007, 129, 6050–
6055.
17. Liljeblad, A.; Kanerva, L. T. Tetrahedron 2006, 62, 5831–
5854.
18. Kanerva, L. T.; Csomos, P.; Sundholm, O.; Bernath, G.;
Fulo¨p, F. Tetrahedron: Asymmetry 1996, 7, 1705–1716.
19. Gedey, S.; Liljeblad, A.; Fulo¨p, F.; Kanerva, L. T. Tetrahe-
(1.8 mmol, 38%); ½aꢁD ¼ þ26:4 (c 1.0, MeOH); ee = 78%}
as a colourless oil. Aqueous KOH (8%) was added to the
aqueous phase and the free amino ester (R)-6 was extracted
with EtOAc. 1H NMR (400 MHz, CDCl3) d (ppm) for (S)-
8: 0.94 (9H, m, (CH3)2CH + COCH2CH2CH3), 1.64 (2H,
m, COCH2CH2CH3), 1.97 (1H, m, (CH3)2CH), 2.12
(2H, t, J = 7.42 Hz, COCH2CH2CH3), 2.47 (1H, m,
(CH3)2CHCH), 3.35 (1H, m, CH2NH), 3.59 (1H, m,
CH2NH), 3.70 (3H, s, OCH3), 5.87 (1H, br s, NH).
´
´
¨
¨
dron: Asymmetry 2001, 12, 105–110.
´
20. Solymar, M.; Fulo¨p, F.; Kanerva, L. T. Tetrahedron:
¨
Asymmetry 2002, 13, 2383–2388.
The enantiomerically enriched substrate (R)-6 (250 mg,
1.7 mmol) was subjected to enzymatic reaction (without
further purification) under the above conditions. After 24
days (ee (R)-6 = 76%, ee (S)-8 = 56%), the reaction was
stopped by filtering off the enzyme. After evaporation,
the free amino ester was transformed into the N-Boc-pro-
´
21. Forro, E.; Fulo¨p, F. Chem. Eur. J. 2007, 13, 6397–6401.
¨
22. Rossi, D.; Lucente, G.; Romeo, A. Experientia 1977, 33,
1557–1559.
´
´ ´
23. Solymar, M.; Liljeblad, A.; Lazar, L.; Fulo¨p, F.; Kanerva, L.
¨
T. Tetrahedron: Asymmetry 2002, 13, 1923–1928.
24. Kaptein, B.; Broxterman, Q. B.; Kierkels, J. G. T.; Milcent,
T. PCT Int. Appl., WO 2005/085462 A1, 2005.
25. Testa, E.; Fontanella, L.; Cristiani, G. F.; Mariani, L. Liebigs
Ann. Chem. 1961, 639, 166–180.
tected form by the method described above and (R)-10
25
{210 mg (0.86 mmol, 18%); ½aꢁD ¼ ꢂ13:4 (c1.0, MeOH);
ee = 76%} was separated from (S)-8 by column chroma-